Blood transfusion and Organ transplant is done to save the life of an individual or to improve patient’s health. Blood bank is an institute from where blood is, stored entirely or as its components (plasma, blood cells and platelets) which is then transfused to the needy patients suffering with deficiency of blood or blood components. Organ Banks are banks which recover, process, storage and distributing an organ as well as body tissue and bone for transplantation. A single organ and tissue donor can save up to 40-50 patients’ lives which marks the importance of blood and organ banks.
Every year million cases either undergo transfusion of blood, blood components, plasma derivatives, and transplantation of organs. According to the World Health Organization (WHO), out of 108 million blood donations done globally, 50% of the blood donations happen in high income countries. More than 65% of blood transfusions in low income countries are given to children below five years of age while the scenario is reverse in high income countries where transfusion is done for elderly patients (age 65 years and above). According to another report by the WHO, voluntary unpaid blood donations have increased tremendously in low- and middle-income nations. From 2004 to 2012, more than 8.6 million blood donations that came from voluntary unpaid donors has increased in 162 countries. Among these countries, there were 73 nations which.
The blood and organ market is segmented on the basis of the following: Products (Blood products which include whole blood, Red blood cells, Platelets, Granulocytes, Fresh frozen plasma, Albumin, Immunoglobulin, Antithrombin III and Protein C concentrate and others (Factor VIIa, Factor VIII Fraction, Dried factor IX fraction, Factor XIII dried) and under Organs include (Kidney, liver, heart, pancreas and cornea).The end users include either the Public Hospitals or the Private Hospitals.
On the basis of geography, the global the blood and organ market can be segmented into North America , Europe, Asia Pacific, Latin America, and Middle East and Africa. North America has been a leading region in the market owing to high demand for organ transplant. Annually, more than 120,000 Americans need a new organ.
Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6907
The blood and organ bank industry has grown healthily in past decades and is expected to continue its growth trajectory during the forecast period from 2015 to 2023. According to the Organ Procurement and Transplantation Network (OPTN), more than 1 million patients are on waiting list for organ transplant. As the number of organ donors is increasing, an increase in transplant procedures is bound to happen this will expand the global market for blood and organ bank market. Moreover, the government efforts for creating awareness for blood donation and restoring donors’ and the patient’s confidence in blood transfusion services has also up stretched the demand for these systems. Rising incidences of accidents are propelling the market for blood and organ banks because in such cases there is high probability of demand for blood or organ. Increasing healthcare insurance coverage, greater improvement in post-transplant outcomes are among other factors that help drive the market growth.
Some of the market players in this industry segment are The American Red Cross, Blood Systems, Musculoskeletal Transplant Foundation, Inc., New York Blood Center, New England Organ Bank, The Living Bank, NOTTO and 21st Century Medicine.
A new market research study, titled “Antibacterial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023,” has been published by Transparency Market Research. As per the study, in 2014, the global antibacterial drugs market was worth US$43.9 bn. The market is projected to exhibit a 1.30% CAGR between 2015 and 2023, declining in value to touch US$38.9 bn by the end of 2023.
The global telepharmacy market has been surging at an exponential rate since the last few years. The market is also poised to exhibit an incredible rate of growth in forthcoming years, as per the findings of Transparency Market Research (TMR). In a new report, titled “Telepharmacy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024” TMR has incorporated various factors and prevailing trends that will shape the trajectory for 
Mice models have long been the backbone of fundamental and applied research in life sciences and continues to grow at a rapid rate. The mice model market has transformed since 2001, the year rodent genome was mapped. Mice models have a wide array of applications such as basic research, developing new therapeutic strategies for the treatment of human diseases, drug discovery and development research (such as target characterization, drug screening, and toxicity and safety evaluation), and preclinical studies of drug efficacy. Hundreds of mice models have been developed to study diseases such as cancer, Huntington’s, Parkinson’s, Duchenne and Becker muscular dystrophy, and amyotrophic lateral sclerosis (ALS). In the last 25 years, around 80% of discoveries in the biomedical research has been linked to research on mice.